Official name: | Republic of Namibia |
---|---|
WRLFMD code: | NMB |
FMD first recorded: | |
FMD eradicated: | |
Subsequent outbreaks: | |
Serotypes (last rpt): | |
Current status: | Sporadic |
Useful websites: |
FMDV Serotype | Years (not comprehensive) |
---|---|
Untyped | 2007, 2015 |
O | 2021 |
A | 1958, 1962, 1967 |
C | - |
Asia 1 | - |
SAT 1 | Livestock: 1949, 1961-1962, 1964, 1980, 1990, 2000, 2010-2013, 2015 Buffalo: 1989, 1998 |
SAT 2 | Livestock: 1968-1969, 1971, 1975, 1978, 1989, 1991-1992, 2007-2008, 2014-2015, 2017, 2021 Buffalo: 1989, 1998, 2021 |
SAT 3 | Livestock: 1994, 2011, 2019, 2020 Buffalo: ? |
Notes | All three SAT serotypes are endemic in the African buffalo (Syncerus caffer) population |
WRLFMD batch no. | Date Received | Virus samples | Type | Topotype | Lineage | Sublineage | WRLFMD Reports |
---|---|---|---|---|---|---|---|
WRLFMD/2004/00014 | 17/05/2004 | NMB/1/2000 | SAT 1 | III (WZ) | - | - | Detection Genotyping(SAT1) |
WRLFMD/2007/00168 | 18/12/2007 | NMB/1/2007 | SAT 2 | III | unnamed | - | Detection Genotyping(SAT2) |
NMB/2/2007* | SAT 2 | nd | - | - | |||
NMB/4/2007 | SAT 2 | III | unnamed | - | |||
NMB/3/2007 | FMDV‑GD | nd | - | - | |||
NMB/5/2007 | FMDV‑GD | nd | - | - | |||
WRLFMD/2008/00018 | 09/06/2008 | NMB/1/2008 | SAT 2 | III | unnamed | - | Detection Genotyping(SAT2) Vaccine(SAT2) Vaccine(SAT2,sup) |
WRLFMD/2008/00026 | 01/08/2008 | NMB/2/2008 | SAT 2 | III | unnamed | - | Detection Genotyping(SAT2) Vaccine(SAT2) Vaccine(SAT2,sup) |
NMB/3/2008 | SAT 2 | III | unnamed | - | |||
NMB/4/2008 | SAT 2 | III | unnamed | - | |||
WRLFMD/2015/00020 | 13/08/2015 | NMB/1/2015 | SAT 1 | III (WZ) | unnamed | - | Detection Genotyping(SAT 1) Genotyping(SAT 2) Vaccine |
NMB/2/2015 | SAT 2 | III | unnamed | - | |||
NMB/3/2015 | SAT 2 | III | unnamed | - | |||
NMB/4/2015 | SAT 2 | III | unnamed | - | |||
NMB/5/2015 | SAT 2 | III | unnamed | - | |||
NMB/6/2015 | SAT 2 | III | unnamed | - | |||
WRLFMD/2016/00026 | 10/06/2016 | NMB/7/2015 | SAT 2 | III | unnamed | - | Detection Genotyping(SAT 2) |
NMB/8/2015 | FMDV‑GD | nd | - | - | |||
NMB/9/2015 | FMDV‑GD | nd | - | - | |||
NMB/10/2015 | NVD | ||||||
WRLFMD/2017/00026 | 19/10/2017 | NMB/1/2017 | NVD | Detection | |||
NMB/2/2017 | NVD | ||||||
WRLMEG/2019/00042 | 25/08/2019 | NAM06/2019† | SAT 3 | II | - | - | Genotyping(SAT 3) |
NAM07/2019† | SAT 3 | II | - | - | |||
WRLMEG/2020/00002 | 15/01/2020 | NAM04/2020† (2019) | SAT 3 | II | - | - | Genotyping(SAT 3) |
WRLMEG/2021/00003 | 25/02/2021 | NAM06/2021† | SAT 2 | III | - | - | Genotyping(SAT 2) |
NAM08/2021† | SAT 2 | III | - | - | |||
WRLMEG/2021/00012 | 13/08/2021 | NAM13/2021† | O | EA-2 | - | - | Geonotyping(O) |
WRLFMD/2023/000108 | 11/12/2023 | NMB 1/2022 | SAT 2 | III | - | - | Detection Genotyping(SAT2) Vaccine |
NMB 2/2022 | SAT 2 | III | - | - |
Notes:
nd, not done
*, no virus isolated on cell culture
†, Not a WRLFMD reference number (only VP1 sequence received)